| Date Filed | Type | Description |
| 10/03/2023 |
4
| Young Caroline (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.65, valued at
$107.3
Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.71, valued at
$111.2
Small acquisition of 65 shares
@ $1.76, valued at
$114.4
Small acquisition of 65 shares
@ $1.83, valued at
$119
Small acquisition of 65 shares
@ $1.84, valued at
$119.6
Small acquisition of 23 shares
@ $1.82, valued at
$41.9
Small acquisition of 55 shares
@ $2.03, valued at
$111.7
Small acquisition of 55 shares
@ $2.12, valued at
$116.6 |
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Young Caroline (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 20 shares
@ $2.57, valued at
$51.4
Bought 20 shares
@ $2.52, valued at
$50.4
Bought 20 shares
@ $2.51, valued at
$50.2
Bought 20 shares
@ $2.61, valued at
$52.2
Bought 20 shares
@ $2.54, valued at
$50.8
Bought 20 shares
@ $2.61, valued at
$52.2
Bought 20 shares
@ $2.58, valued at
$51.6
Bought 20 shares
@ $2.65, valued at
$53
Bought 20 shares
@ $2.66, valued at
$53.2
Bought 20 shares
@ $2.53, valued at
$50.6
Bought 20 shares
@ $2.48, valued at
$49.6 |
|
| 09/30/2022 |
4
| Young Caroline (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 20 shares
@ $2.35, valued at
$47
Bought 20 shares
@ $2.31, valued at
$46.2
Bought 20 shares
@ $2.23, valued at
$44.6
Bought 20 shares
@ $2.35, valued at
$47
Bought 20 shares
@ $2.51, valued at
$50.2
Bought 20 shares
@ $2.59, valued at
$51.8
Bought 20 shares
@ $2.59, valued at
$51.8
Bought 20 shares
@ $2.62, valued at
$52.4
Bought 20 shares
@ $2.55, valued at
$51
Bought 22 shares
@ $2.44, valued at
$53.7
Bought 22 shares
@ $2.38, valued at
$52.4 |
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2022 |
4
| Young Caroline (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 18 shares
@ $4.14, valued at
$74.5
Bought 18 shares
@ $3.84, valued at
$69.1
Bought 18 shares
@ $4.47, valued at
$80.5
Bought 18 shares
@ $4.46, valued at
$80.3
Bought 18 shares
@ $5.61, valued at
$101
Bought 18 shares
@ $6.15, valued at
$110.7
Bought 18 shares
@ $5.81, valued at
$104.6
Bought 18 shares
@ $4.82, valued at
$86.8
Bought 30 shares
@ $4.36, valued at
$130.8
Bought 30 shares
@ $4.28, valued at
$128.4
Bought 30 shares
@ $4.29, valued at
$128.7 |
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2021 |
4
| Young Caroline (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 15 shares
@ $2.69, valued at
$40.4
Bought 15 shares
@ $2.87, valued at
$43.1
Bought 15 shares
@ $2.82, valued at
$42.3
Bought 15 shares
@ $2.76, valued at
$41.4
Bought 15 shares
@ $2.76, valued at
$41.4
Bought 15 shares
@ $2.84, valued at
$42.6
Bought 15 shares
@ $2.73, valued at
$41
Bought 15 shares
@ $2.71, valued at
$40.7
Bought 15 shares
@ $2.71, valued at
$40.7
Bought 15 shares
@ $2.81, valued at
$42.2
Bought 15 shares
@ $2.76, valued at
$41.4 |
|
| 10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 04/17/2020 |
4
| Young Caroline (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Granted 1,000 shares
@ $3.56, valued at
$3.6k
|
|
| 10/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2019 |
4
| Young Caroline (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 183 shares
@ $6.29, valued at
$1.2k
Bought 50 shares
@ $6.31, valued at
$315.5
Bought 50 shares
@ $6.28, valued at
$314
Bought 34 shares
@ $6.14, valued at
$208.8
Bought 19 shares
@ $6.07, valued at
$115.3
Bought 22 shares
@ $5.96, valued at
$131.1
Bought 26 shares
@ $5.92, valued at
$153.9
Bought 18 shares
@ $5.79, valued at
$104.2
Bought 48 shares
@ $5.38, valued at
$258.2
Bought 43 shares
@ $6.15, valued at
$264.5
Bought 76 shares
@ $5.91, valued at
$449.2 |
|
| 03/22/2019 |
4
| Young Caroline (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Granted 1,000 shares
@ $5.98, valued at
$6k
|
|
| 03/23/2018 |
4
| Young Caroline (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Granted 1,000 shares
@ $6.7, valued at
$6.7k
|
|
| 04/07/2017 |
4
| Young Caroline (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Granted 2,000 shares
@ $6.45, valued at
$12.9k
|
|
| 09/16/2016 |
3
| Young Caroline (Director) has filed a Form 3 on CUMBERLAND PHARMACEUTICALS INC |